Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 18 | 2024 | 706 | 3.440 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 13 | 2017 | 98 | 3.410 |
Why?
|
| Virus Replication | 9 | 2024 | 278 | 2.520 |
Why?
|
| Virus Integration | 12 | 2017 | 58 | 2.210 |
Why?
|
| HIV Integrase | 11 | 2017 | 20 | 1.810 |
Why?
|
| Chromatin | 11 | 2017 | 169 | 1.520 |
Why?
|
| Cell Line | 21 | 2019 | 1354 | 1.150 |
Why?
|
| Transcription Factors | 6 | 2016 | 681 | 1.000 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2016 | 190 | 0.950 |
Why?
|
| Fullerenes | 3 | 2021 | 31 | 0.890 |
Why?
|
| Sequence Deletion | 3 | 2017 | 87 | 0.760 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 186 | 0.740 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 4 | 0.690 |
Why?
|
| DNA, Viral | 3 | 2017 | 304 | 0.690 |
Why?
|
| Retroviridae | 2 | 2012 | 22 | 0.690 |
Why?
|
| Avian leukosis virus | 3 | 2016 | 7 | 0.680 |
Why?
|
| Flavivirus | 1 | 2019 | 15 | 0.680 |
Why?
|
| Anti-HIV Agents | 3 | 2021 | 420 | 0.670 |
Why?
|
| Viral Proteins | 3 | 2017 | 174 | 0.650 |
Why?
|
| DNA, Complementary | 2 | 2017 | 191 | 0.640 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 307 | 0.600 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 45 | 0.600 |
Why?
|
| Viruses | 1 | 2017 | 36 | 0.600 |
Why?
|
| Antiviral Agents | 2 | 2017 | 157 | 0.570 |
Why?
|
| High Mobility Group Proteins | 1 | 2016 | 4 | 0.560 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 6 | 0.560 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2016 | 7 | 0.550 |
Why?
|
| Heterochromatin | 1 | 2016 | 16 | 0.550 |
Why?
|
| RNA Interference | 6 | 2009 | 243 | 0.530 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 259 | 0.500 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 539 | 0.500 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 171 | 0.480 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 173 | 0.480 |
Why?
|
| HIV | 3 | 2009 | 98 | 0.460 |
Why?
|
| Virion | 4 | 2021 | 69 | 0.440 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 78 | 0.430 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 578 | 0.420 |
Why?
|
| Humans | 29 | 2024 | 37093 | 0.410 |
Why?
|
| Lentivirus | 3 | 2008 | 21 | 0.390 |
Why?
|
| Protein Binding | 7 | 2021 | 972 | 0.390 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2024 | 110 | 0.380 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 61 | 0.380 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 11 | 0.370 |
Why?
|
| SUMO-1 Protein | 1 | 2010 | 10 | 0.370 |
Why?
|
| Ubiquitins | 1 | 2010 | 46 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 515 | 0.350 |
Why?
|
| Serine | 1 | 2009 | 75 | 0.340 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 172 | 0.340 |
Why?
|
| Integrases | 2 | 2004 | 26 | 0.310 |
Why?
|
| HIV Protease Inhibitors | 2 | 2016 | 23 | 0.280 |
Why?
|
| Cells, Cultured | 5 | 2017 | 1518 | 0.260 |
Why?
|
| Codon | 2 | 2024 | 42 | 0.250 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2009 | 114 | 0.250 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 188 | 0.250 |
Why?
|
| Oncogenic Viruses | 1 | 2004 | 2 | 0.250 |
Why?
|
| Chickens | 2 | 2016 | 133 | 0.230 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 133 | 0.230 |
Why?
|
| RNA, Messenger | 3 | 2024 | 1207 | 0.230 |
Why?
|
| Caveolins | 1 | 2002 | 8 | 0.220 |
Why?
|
| Genome, Viral | 2 | 2021 | 109 | 0.210 |
Why?
|
| Nucleocapsid Proteins | 1 | 2021 | 9 | 0.210 |
Why?
|
| Cell Survival | 3 | 2016 | 864 | 0.210 |
Why?
|
| Nuclear Localization Signals | 3 | 2006 | 17 | 0.200 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 18 | 0.190 |
Why?
|
| Gene Expression | 2 | 2019 | 674 | 0.180 |
Why?
|
| RNA, Viral | 1 | 2021 | 301 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.170 |
Why?
|
| RNA Viruses | 1 | 2019 | 22 | 0.170 |
Why?
|
| RNA, Transfer | 1 | 2019 | 28 | 0.170 |
Why?
|
| Mason-Pfizer monkey virus | 1 | 2018 | 1 | 0.160 |
Why?
|
| Virus Assembly | 1 | 2018 | 41 | 0.160 |
Why?
|
| Animals | 9 | 2016 | 15081 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2009 | 295 | 0.160 |
Why?
|
| Terminal Repeat Sequences | 1 | 2017 | 8 | 0.150 |
Why?
|
| Capsid Proteins | 1 | 2018 | 67 | 0.150 |
Why?
|
| Cysteine | 1 | 2018 | 98 | 0.150 |
Why?
|
| Histone Chaperones | 1 | 2017 | 2 | 0.150 |
Why?
|
| Kinetics | 1 | 2019 | 708 | 0.150 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2231 | 0.150 |
Why?
|
| HIV Core Protein p24 | 1 | 2016 | 10 | 0.140 |
Why?
|
| Transfection | 4 | 2014 | 523 | 0.140 |
Why?
|
| Histones | 2 | 2016 | 190 | 0.140 |
Why?
|
| Pyrrolidines | 1 | 2016 | 29 | 0.140 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 63 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2010 | 173 | 0.140 |
Why?
|
| HIV Infections | 3 | 2024 | 2303 | 0.140 |
Why?
|
| Gene Deletion | 2 | 2009 | 166 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 56 | 0.130 |
Why?
|
| DNA Replication | 1 | 2016 | 152 | 0.130 |
Why?
|
| Drosophila | 1 | 2016 | 144 | 0.130 |
Why?
|
| Gene Products, rev | 2 | 2004 | 4 | 0.120 |
Why?
|
| Genetic Vectors | 2 | 2018 | 158 | 0.120 |
Why?
|
| Leukemia Virus, Murine | 1 | 2012 | 3 | 0.110 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2012 | 7 | 0.110 |
Why?
|
| Jurkat Cells | 1 | 2012 | 79 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 51 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 172 | 0.110 |
Why?
|
| DNA | 2 | 2005 | 574 | 0.100 |
Why?
|
| Mutation | 3 | 2018 | 1095 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1568 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 408 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 42 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2011 | 51 | 0.100 |
Why?
|
| Proviruses | 2 | 2018 | 29 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 277 | 0.090 |
Why?
|
| Half-Life | 1 | 2010 | 54 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2014 | 176 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 132 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 336 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 623 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1180 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 807 | 0.080 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2007 | 2 | 0.080 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2004 | 3 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2005 | 59 | 0.080 |
Why?
|
| Antigens, Viral | 2 | 2009 | 43 | 0.070 |
Why?
|
| Virulence | 1 | 2007 | 223 | 0.070 |
Why?
|
| Mice | 5 | 2009 | 5913 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 35 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 357 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 183 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2005 | 859 | 0.070 |
Why?
|
| Amino Acids | 1 | 2006 | 145 | 0.060 |
Why?
|
| Macrophages | 1 | 2009 | 439 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2009 | 308 | 0.060 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2004 | 2 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 49 | 0.060 |
Why?
|
| Introns | 1 | 2004 | 75 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 131 | 0.060 |
Why?
|
| Genes, vpu | 1 | 2004 | 1 | 0.060 |
Why?
|
| Genes, vif | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2004 | 143 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 78 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 218 | 0.060 |
Why?
|
| Plasmids | 1 | 2004 | 246 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 252 | 0.060 |
Why?
|
| Respirovirus | 1 | 2002 | 3 | 0.050 |
Why?
|
| HIV-2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Defective Viruses | 1 | 2002 | 11 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2002 | 29 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2004 | 366 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2002 | 20 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 26 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2002 | 33 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 189 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 21 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 25 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 36 | 0.050 |
Why?
|
| Reverse Transcription | 1 | 2021 | 18 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2002 | 54 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2002 | 174 | 0.050 |
Why?
|
| Nucleosomes | 1 | 2017 | 29 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 43 | 0.040 |
Why?
|
| HIV Protease | 1 | 2016 | 21 | 0.040 |
Why?
|
| Base Sequence | 2 | 2009 | 997 | 0.040 |
Why?
|
| Cations | 1 | 2016 | 45 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 201 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 409 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 492 | 0.030 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2014 | 25 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1039 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 409 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 893 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2014 | 249 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2008 | 26 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 208 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 142 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2005 | 61 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2005 | 25 | 0.020 |
Why?
|
| Cats | 1 | 2005 | 69 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 61 | 0.020 |
Why?
|
| Vero Cells | 1 | 2005 | 93 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2005 | 151 | 0.020 |
Why?
|
| Protein Transport | 1 | 2005 | 302 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 326 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 1 | 0.010 |
Why?
|
| HLA-C Antigens | 1 | 2002 | 4 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 2002 | 7 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2002 | 10 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 2002 | 11 | 0.010 |
Why?
|
| Clone Cells | 1 | 2002 | 47 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 24 | 0.010 |
Why?
|
| Biopolymers | 1 | 2002 | 18 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 121 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 83 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 92 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 211 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 290 | 0.010 |
Why?
|
| Female | 1 | 2014 | 20969 | 0.010 |
Why?
|